Carnitine Analog class drugs

2 results
  • levocarnitine

    (Levocarnitine)
    ANI Pharmaceuticals, Inc.
    Levocarnitine is indicated for treating primary systemic carnitine deficiency, characterized by Reye-like encephalopathy, hypoketotic hypoglycemia, and cardiomyopathy. It also addresses secondary carnitine deficiency due to inborn errors of metabolism. Treatment may include supportive care alongside levocarnitine supplementation.
  • levocarnitine

    (Levocarnitine)
    ANI Pharmaceuticals, Inc.
    Levocarnitine is indicated for treating primary systemic carnitine deficiency, characterized by symptoms like Reye-like encephalopathy, hypoketotic hypoglycemia, and cardiomyopathy. It is also used for acute and chronic treatment of secondary carnitine deficiency due to inborn metabolic errors. Supportive therapy is recommended alongside treatment.